Pfizer (PFE) Net Income (2009 - 2026)
Pfizer (PFE) reported Net Income of -$13.0 million for Q1 2026, down 152.0% on a QoQ basis from $25.0 million in Q2 2025.
Pfizer (PFE) has 18 years of Net Income data on file, last reported at -$13.0 million in Q1 2026.
- Quarterly Net Income changed N/A year-over-year to -$13.0 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $12.0 million (up 33.33% YoY) and the FY2025 annual result came in at $25.0 million, up 127.27% from the prior year.
- Net Income slipped to -$13.0 million in Q1 2026 per PFE's latest filing, from $25.0 million in the prior quarter.
- Across five years, Net Income topped out at $34.0 million in Q3 2022 and bottomed at -$26.0 million in Q4 2023.
- The 5-year median for Net Income is -$3.5 million (2023), against an average of $416666.7.
- The widest annual swing landed in 2022, when Net Income plunged 1000.0%; it then jumped 950.0% in 2024.
- Tracing PFE's Net Income over 5 years: stood at -$21.0 million in 2022, then retreated by 23.81% to -$26.0 million in 2023, then jumped by 69.23% to -$8.0 million in 2024, then surged by 412.5% to $25.0 million in 2025, then tumbled by 152.0% to -$13.0 million in 2026.
- Per Business Quant, the three latest PFE Net Income figures stand at -$13.0 million (Q1 2026), $25.0 million (Q2 2025), and -$8.0 million (Q3 2024).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Income (Qtr) |
|---|---|---|---|---|---|
| 1 | Novartis Ag | 107,124,802.25 Bn | 107,124,802.25 Bn | - | - |
| 2 | Eli Lilly | 969.00 Bn | 963.72 Bn | 16.22 Bn | 7.40 Bn |
| 3 | Johnson & Johnson | 539.46 Bn | 517.41 Bn | 15.96 Bn | 5.24 Bn |
| 4 | AbbVie | 376.92 Bn | 367.57 Bn | 10.78 Bn | 697.00 Mn |
| 5 | Merck | 285.00 Bn | 279.35 Bn | 12.09 Bn | -4.21 Bn |
| 6 | Amgen | 177.58 Bn | 165.55 Bn | 5.87 Bn | 1.82 Bn |
| 7 | Gilead Sciences | 163.22 Bn | 155.50 Bn | 5.52 Bn | 2.02 Bn |
| 8 | Pfizer | 145.86 Bn | 133.09 Bn | -1.21 Bn | -13.00 Mn |
| 9 | Bristol Myers Squibb | 111.90 Bn | 101.44 Bn | 8.07 Bn | 2.68 Bn |
| 10 | Gsk | 88.34 Bn | 83.66 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 29, 2026 | -13.00 Mn |
| Jun 29, 2025 | 25.00 Mn |
| Sep 29, 2024 | -8.00 Mn |
| Jun 30, 2024 | 17.00 Mn |
| Mar 31, 2024 | -5.00 Mn |
| Dec 31, 2023 | -26.00 Mn |
| Oct 1, 2023 | 12.00 Mn |
| Jul 2, 2023 | -2.00 Mn |
| Apr 2, 2023 | 1.00 Mn |
| Oct 2, 2022 | -21.00 Mn |
| Jul 3, 2022 | 34.00 Mn |
| Apr 3, 2022 | -9.00 Mn |
| Oct 3, 2021 | -13.00 Mn |
| Jul 4, 2021 | -236.00 Mn |
| Apr 4, 2021 | 1.00 Mn |
| Sep 27, 2020 | 560.00 Mn |
| Jun 28, 2020 | 893.00 Mn |
| Mar 29, 2020 | 881.00 Mn |
| Dec 31, 2019 | 5.31 Bn |
| Sep 29, 2019 | 4.00 Mn |
| Dec 31, 2018 | 7.32 Bn |
| Sep 30, 2018 | 11.00 Mn |
| Apr 1, 2018 | -1.00 Mn |
| Dec 31, 2017 | 2.00 Mn |
| Jul 2, 2017 | 2.00 Mn |
| Dec 31, 2016 | 16.00 Mn |
| Jul 3, 2016 | 1.00 Mn |
| Dec 31, 2015 | -20.00 Mn |
| Sep 27, 2015 | 8.00 Mn |
| Jun 28, 2015 | 1.00 Mn |
| Mar 29, 2015 | 5.00 Mn |
| Dec 31, 2014 | -15.00 Mn |
| Sep 28, 2014 | -3.00 Mn |
| Mar 30, 2014 | 73.00 Mn |
| Dec 31, 2013 | -57.00 Mn |
| Sep 29, 2013 | 11.00 Mn |
| Jun 30, 2013 | 10.56 Bn |
| Mar 31, 2013 | 149.00 Mn |
| Dec 31, 2012 | 4.05 Bn |
| Sep 30, 2012 | 225.00 Mn |
| Apr 1, 2012 | 79.00 Mn |
| Dec 31, 2011 | 1.89 Bn |
| Oct 2, 2011 | 96.00 Mn |
| Jul 3, 2011 | 97.00 Mn |
| Apr 3, 2011 | 10.00 Mn |
| Dec 31, 2010 | -95.00 Mn |
| Oct 3, 2010 | 26.00 Mn |
| Jul 4, 2010 | 31.00 Mn |
| Apr 4, 2010 | 19.00 Mn |
| Dec 31, 2009 | 11.00 Mn |
| Sep 27, 2009 | 2.00 Mn |
| Jun 28, 2009 | 3.00 Mn |
| Mar 29, 2009 | 1.00 Mn |